Compared to serum AFP, cfDNA-derived AFP demonstrated significantly greater diagnostic accuracy in distinguishing HCC patients from non-cancerous individuals (p < 0.0001, AUC = 0.998), while AFP+ CTCs showed high specificity. Here, AFP is linked to hepatocellular carcinoma.